Sanofi Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (106)

Latest Posts

About This Stock More About This Stock
The Trump Effect: How Trump's Policies Moved Stocks This Past Week
Article By: The Fly
Sunday, August 2, 2020 8:45 AM EDT
Trump says drug prices to be "lowered massively," Chinese-backed hackers reportedly behind Moderna attack.
In this article: L, AZN, BMY, GSK, JNJ, LLY, MRK, NVS, PFE, SNY, RHHBY, AAPL, AMZN, GOOG, MSFT, MRNA, SNAP, FB, TWTR, GOOGL, KODK
Read
E Protalix BioTherapeutics Pipeline Progress
Article By: Terry Chrisomalis
Wednesday, July 29, 2020 9:54 AM EDT
Protalix Biotherapeutics (PLX) offers great potential in the coming months as its lead candidate, PLX-102 - a therapy for Fabry disease, is edging closer to the finish line.
In this article: PLX, SNY Also: ITMR, BLRX, BCLI, BLPH, PSTI
Read
These Are Some Of The Coronavirus Vaccine Candidates
Article By: ValueWalk
Monday, May 25, 2020 6:28 PM EDT
As far as which coronavirus vaccine candidates will be tested first, researchers will look at production capacity and the amount of immune response generated in early trials and animal studies.
In this article: GSK, PFE, SNY, MRNA, ALT, JNJ, SVA, NVAX, INO, AZN
Read
Sanofi To Sell Investment In Regeneron, Says Will Not Impact Collaboration
Article By: The Fly
Monday, May 25, 2020 3:22 PM EDT
Sanofi announced its intent to sell its equity investment in Regeneron Pharmaceuticals through a registered public offering. The registered offering and share repurchase will have no impact on the ongoing collaboration between the two.
In this article: SNY, REGN
Read
Week In Review: How Trump's Policies Moved Stocks - Saturday, May 23
Article By: The Fly
Saturday, May 23, 2020 6:13 PM EDT
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump and his administration.
In this article: AZN, JNJ, MRK, NPTN, NVS, SNY, BAYRY, MYL, TEVA, MRNA, LITE
Read

PARTNER HEADLINES

Latest Tweets for $SNY

No tweets yet!

$SNY

Protalix BioTherapeutics Pipeline Progress
Harry Goldstein 8/10/2020 6:01:37 AM

#Protalix clearly has a lot of potential but there's a limited number of people who will need this drug. So the real question is how much of a dent will they put into #Sanofi's market share. $PLX $SNY

Protalix BioTherapeutics Pipeline Progress
Old Time Investor 8/3/2020 2:23:12 PM

My pleasure. What's more important than how prevalent the disease is, is how much money #Protalix can make on its new drug. It's competitor, #Sanofi ($SNY) makes $1 billion in revenue annually on their drug. Protalix's sounds like a more promising alternative. I'd definitely rate $PLX a buy.

1 to 2 of 2 comments